Showing 1 - 3 results of 3 for search 'Toby A. Eyre' Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Author
  • Toby A. Eyre
Showing 1 - 3 results of 3 for search 'Toby A. Eyre', query time: 0.04s Refine Results
  1. 1
    Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients.
    Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients.
    by Faouzi Djebbari, Faye A Sharpley, Susan McLain-Smith, Grant Vallance, Toby A Eyre, Jaimal Kothari, Sally Moore, Karthik Ramasamy
    Published 2020-01-01
    Get full text
    Article
  2. 2
    The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease
    The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly dia...
    by Niamh Appleby, Toby A. Eyre, Maite Cabes, Aimee Jackson, Rebecca Boucher, Francesca Yates, Sonia Fox, Andrew Rawstron, Peter Hillmen, Anna Schuh
    Published 2019-05-01
    Get full text
    Article
  3. 3
    A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma
    A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma
    by Stephen W. Booth, Toby A. Eyre, John Whittaker, Leticia Campo, Lai Mun Wang, Elizabeth Soilleux, Daniel Royston, Gabrielle Rees, Murali Kesavan, Catherine Hildyard, Farasat Kazmi, Nick La Thangue, David Kerr, Mark R. Middleton, Graham P. Collins
    Published 2021-07-01
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...